Mercado de dispositivos de biopsia: mapeo competitivo y perspectivas estratégicas para 2031

  • Report Code : TIPHE100001402
  • Category : Medical Device
  • Status : Published
  • No. of Pages : 196
Buy Now

Se prevé que el mercado de dispositivos de biopsia alcance los 3.584,20 millones de dólares en 2027, frente a los 2.230,86 millones de dólares de 2019. Se prevé que el mercado crezca a una tasa compuesta anual del 6,2 % de 2020 a 2027.

  ;

Una biopsia es un examen médico generalmente realizado por cirujanos, radiólogos intervencionistas o cardiólogos intervencionistas para extraer una muestra de células o tejidos; Estos exámenes ayudan en la identificación y determinación de enfermedades. Los patólogos generalmente observan el tejido bajo un microscopio y también pueden examinarlo químicamente. Las biopsias se realizan con mayor frecuencia para identificar afecciones cancerosas e inflamatorias.

regiones lucrativas para el mercado de dispositivos de biopsia

Perspectivas del mercado

Aumento de las tasas de cáncer

La biopsia se refiere a una prueba de diagnóstico que ayuda a identificar varios tipos de cáncer y anomalías no cancerosas en el cuerpo humano. Es probable que la creciente prevalencia del cáncer entre la población aumente el crecimiento del mercado de dispositivos de biopsia en todo el mundo. Por ejemplo, en Canadá, el cáncer es la principal causa de muerte entre la población y, en Estados Unidos, se considera la segunda causa después de las enfermedades cardíacas. Según la Sociedad Estadounidense del Cáncer, en 2018 se registraron ~1,9 millones de nuevos casos de cáncer y 693 000 muertes por cáncer. Los cánceres de próstata son los cánceres más comúnmente diagnosticados entre los hombres en América del Norte; sin embargo, el cáncer de mama sigue siendo el más frecuente entre las mujeres. Además, el cáncer de pulmón sigue siendo la causa más común de muerte en ambos sexos. Se estima que el número de nuevos casos de incidencia de cáncer es de 439,2 por cada 100.000 hombres y mujeres al año.

Según el Perfil Nacional de Salud, los casos de cánceres comunes, incluidos los cánceres de cuello uterino, oral y de mama, aumentaron un 324 % en la India entre 2017 y 2018. Además, el número total de pacientes que visitan clínicas de enfermedades no transmisibles (ENT) se duplicó entre 2017 y 2018, cifra que se registra en 35 millones y 66 millones, respectivamente. El rápido cambio en el estilo de vida y el consumo de alcohol y productos de tabaco se encuentran entre los factores destacados que aumentan la incidencia de cáncer entre la población.

BD, Qiagen, F.Hoffmann La-Roche Ltd., Hologic y Boston Scientific Corporation se encuentran entre las principales empresas que fabrican dispositivos y accesorios de biopsia para diagnosticar el cáncer y otras enfermedades. Por lo tanto, se espera que la creciente prevalencia del cáncer en todo el mundo impulse el crecimiento del mercado mundial de dispositivos de biopsia durante el período de pronóstico.

Perspectivas del mercado basadas en productos

El mercado de dispositivos de biopsia está segmentado según el producto en biopsia con aguja, bandejas de procedimiento, cables de localización y otros. En 2019, el segmento de biopsia con aguja representó la mayor parte del mercado mundial de dispositivos de biopsia. El crecimiento del mercado para este segmento se atribuye a la creciente adopción de procedimientos de biopsia con aguja debido a su alta precisión, con lesiones mínimas. Además, también es probable que el segmento sea testigo de la CAGR más rápida del mercado durante los años previstos.

Mercado global de dispositivos de biopsia, por producto: 2019 y 2027

Perspectivas del mercado basadas en la tecnología

Basado en la tecnología, el mercado mundial de dispositivos de biopsia se segmenta en tomografía computarizada guiada por ultrasonido. biopsia, biopsia estereotáxica, resonancia magnética y otros. En 2019, el segmento de biopsia guiada por ultrasonido ocupó la mayor cuota de mercado. Sin embargo, se prevé que el segmento de tomografía computarizada registre una CAGR significativa durante el período de pronóstico.

Información del mercado basada en aplicaciones

La biopsia global El mercado de dispositivos, según la aplicación, se segmenta en biopsia de pulmón, biopsia de riñón, biopsia de hígado, biopsia de mama y otros. En 2019, el segmento de biopsia de mama tuvo la mayor participación del mercado y también se espera que registre la CAGR más alta durante 2020-2027.

Perspectivas estratégicas

Las asociaciones, los lanzamientos de productos y las adquisiciones son las estrategias más comúnmente adoptadas por las empresas para expandir su presencia en todo el mundo y satisfacer la creciente demanda ampliando sus carteras de productos. Por ejemplo, en diciembre de 2017, BD, un proveedor líder de tecnología médica, adquirió CR Bard, Inc. Esta adquisición ha creado un nuevo líder de la industria de la salud en el mercado global. Bard, con su sólida cartera de productos y su línea de innovación, ha aumentado el alcance de las oportunidades en el negocio de dispositivos médicos de rápido crecimiento en los mercados globales.

Mercado global de dispositivos de biopsia: ; Por producto

  • Biopsia con aguja
    • Dispositivos de biopsia central
    • Agujas de biopsia por aspiración
    • Dispositivos de biopsia asistida por vacío (VAB)
  • Alambres de localización
  • Bandejas de procedimientos
  • Otros

Mercado global de dispositivos de biopsia y ndash ; Por tecnología

  • Tomografía computarizada
  • Biopsia guiada por ultrasonido
  • Biopsia guiada estereotáctica
  • Biopsia guiada por resonancia magnética
  • Otros

Mercado global de Dispositivos de biopsia: ndash; Por Aplicación

  • Biopsia de Pulmón
  • Biopsia de Riñón
  • Biopsia de Hígado
  • Biopsia de Mama
  • Otras< /li>

Mercado de dispositivos de biopsia - ndash; Por geografía

  • América del Norte
    • Estados Unidos
    • Canadá
    • México
  • < li>Europa
    • Francia
    • Alemania
    • Italia
    • Reino Unido
    • España
    • Suecia
    • Dinamarca
    • Noruega
  • Asia Pacífico
    • China
    • India
    • Corea del Sur
    • Japón
    • Australia
  • Oriente Medio y África
    • Sudáfrica
    • Arabia Saudita
    • EAU
  • América del Sur y Central
    • Brasil
    • Argentina

Perfiles de empresas

  • BD
  • B . Braun Melsungen AG
  • Boston Scientific Corporation
  • Cardinal Health, Inc.
  • Cook Medical LLC
  • Danaher
  • Fujifilm Corporation
  • Hologic, Inc.
  • Medtronic
  • Dispositivos médicos de argón
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is biopsy?

A biopsy is a medical examination generally implemented by a surgeon, interventional radiologist, or an interventional cardiologist to extract sample cells or tissues and helps in identification, existence of a disease. The tissue is generally observed under a microscope by a pathologist, and can also be examined chemically. Biopsies are most commonly performed to identify cancerous and inflammatory conditions.

What are the driving factors for the biopsy devices market across the globe?

The biopsy devices market is anticipated to grow with a significant rate in the coming years, owing to factors such as rising patient awareness on cancer and the improvement in biopsy procedures. Increasing incidences of cancer such as breast, prostate, & lung, and rapid technological advancements, initiatives to spread awareness about cancer are expected to offer growth opportunities for the players operating in the market.

What is the regional analysis in terms of biopsy devices market?

North America is the largest market for the biopsy devices market. The factors that are responsible for the dominance of the region include rising government support through the for cancer care in the US and Canada, rising incidence of cancer patients leading to increased demand in kits and products used for testing and diagnosis, increasing awareness among general populace regarding advantages of early testing of diseases and consistent development and launch of novel biopsy products in the market through advanced and extensive research and development. The biopsy devices market in the US is expected to be the largest in the North American region. The growth of the market in the country is attributed to the active participation and support of the government towards the cancer care. Besides this, the increase in the number of cancer population and the technological developments in biopsy devices are likely to help in the growth of the market.

The List of Companies - Biopsy Devices Market

  1. BD
  2. B. Braun Melsungen AG
  3. Boston Scientific Corporation
  4. Cardinal Health, Inc.
  5. Cook Medical LLC
  6. Danaher
  7. Fujifilm Corporation
  8. Hologic, Inc.
  9. Medtronic
  10. Argon Medical Devices

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports